Mct1 Is a New Prognostic Biomarker and Its Therapeutic Inhibition Boosts Response to Temozolomide in Human Glioblastoma
AuthID
P-00V-7MZ
P-00V-7MZ
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service